Hybrid Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists. Our CEO Gregg Siegal attended the event and participated in many interesting and educational discussions. Conference website

Hybrid ZoBio attended the 8th RSC-BMCS Fragment-based Drug Discovery meeting which was taking place in Cambridge on the 27-29 March 2022. The meeting focused on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programs. Great scientific program and fantastic atmosphere delivered a truly memorable conference!…

Fulltime

Fulltime